126 related articles for article (PubMed ID: 10065740)
1. Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals.
Ghose AC; Mookerjee A; Sengupta K; Ghosh AK; Dasgupta S; Ray PK
Immunol Lett; 1999 Feb; 65(3):175-81. PubMed ID: 10065740
[TBL] [Abstract][Full Text] [Related]
2. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
4. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
[TBL] [Abstract][Full Text] [Related]
5. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
Sharma P; Singh N; Garg R; Haq W; Dube A
Peptides; 2004 Nov; 25(11):1873-81. PubMed ID: 15501518
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.
Adhikari A; Gupta G; Majumder S; Banerjee S; Bhattacharjee S; Bhattacharya P; Kumari S; Haldar S; Majumdar SB; Saha B; Majumdar S
PLoS One; 2012; 7(7):e40265. PubMed ID: 22792256
[TBL] [Abstract][Full Text] [Related]
8. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
Joshi J; Kaur S
Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
10. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
[TBL] [Abstract][Full Text] [Related]
11. Adjunct effect of immunostimulating hexapeptide analogous to human beta-casein fragment (54-59) to sodium stibogluconate against experimental visceral leishmaniasis.
Gupta S; Srivastava VM; Puri A; Pandey D; Haq W
Immunopharmacol Immunotoxicol; 2004 Aug; 26(3):425-34. PubMed ID: 15518175
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin, levamisole and thymic extract for chemotherapy and immunostimulation of visceral leishmaniasis in hamsters and mice.
Rifaat LK; Mohammad MA; Jawdat SZ
Jpn J Med Sci Biol; 1989 Apr; 42(2):51-61. PubMed ID: 2561164
[TBL] [Abstract][Full Text] [Related]
13. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
[TBL] [Abstract][Full Text] [Related]
14. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
Sinha R; Roychoudhury J; Palit P; Ali N
Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
[TBL] [Abstract][Full Text] [Related]
15. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
Kar S; Kar K; Bhattacharya PK; Ghosh DK
Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
[TBL] [Abstract][Full Text] [Related]
16. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
17. Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations.
Banduwardene R; Mullen AB; Carter KC
Int J Immunopharmacol; 1997 Apr; 19(4):195-203. PubMed ID: 9373770
[TBL] [Abstract][Full Text] [Related]
18. Activity of rutin, a potent flavonoid against SSG-sensitive and -resistant Leishmania donovani parasites in experimental leishmaniasis.
Chauhan K; Kaur G; Kaur S
Int Immunopharmacol; 2018 Nov; 64():372-385. PubMed ID: 30245348
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor promotes killing of Leishmania donovani by macrophages through the induction of hydrogen peroxide.
Chiba R; Amagai Y; Tanaka A; Katakura K; Matsuda H
Microbes Infect; 2014 Aug; 16(8):702-6. PubMed ID: 24937592
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
Pal S; Ravindran R; Ali N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
